CD19 and Miyoshi myopathy: When pooling the patients with MM and AL, both CD24 and CD19 expression levels were found to be significantly correlated with PFS, with a hazard ratio (HR) of 0.975 (p = 0.002) and 1.025 (p < 0.001), respectively (Table 4).